Thermal stability and decompositions kinetics under non-isothermal conditions of imatinib mesylate α form

J Pharm Biomed Anal. 2016 Sep 10:129:9-14. doi: 10.1016/j.jpba.2016.06.032. Epub 2016 Jun 21.

Abstract

The thermal decomposition and kinetic parameters of synthetized imatinib mesylate α form α form were determined by thermogravimetry (TGA/DTG) under non-isothermal conditions. The experiments were performed at a 25-940°C temperature range at five different heating rates: 2.5Kmin(-1), 5Kmin(-1), 10Kmin(-1), 15Kmin(-1) and 20Kmin(-1) per minute in a nitrogen atmosphere. Imatinib mesylate α form presents one-step mass loss during the degradation process. The thermal stability of the examined material, the melting temperature (Tonset=220.6°C) and ΔH fusion=-95.74Jg(-1) at a heating rate of 10°Cmin(-1) was established. The values of activation energies have been estimated using Kissinger, Flynn-Wall-Ozawa (FWO) and Kissinger-Akahira-Sunose (KAS) methods.

Keywords: DSC; Imatinib mesylate α TGA/DTG; activation energy; form; non-isothermal.

MeSH terms

  • Drug Compounding
  • Drug Stability
  • Hot Temperature* / adverse effects
  • Imatinib Mesylate / chemistry*
  • Imatinib Mesylate / pharmacokinetics*
  • Kinetics
  • Temperature
  • Thermogravimetry / methods
  • X-Ray Diffraction / methods

Substances

  • Imatinib Mesylate